PATZ1 and non-small cell lung carcinoma: Thus, overexpression of PATZ1 can attenuate EMT in NSCLC cells, with upregulation in the expression of the epithelial marker E-cadherin and concomitant downregulation of the mesenchymal marker vimentin.